New York State Common Retirement Fund Fibrogen Inc Transaction History

New York State Common Retirement Fund

$73.9 Billion
Q3 2024

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 31, 2024	SELL	$0.89 - $2.36 $31,023 - $82,264	-34,858 Reduced 97.81%	779 $1,000
Q1 2024 May 07, 2024	SELL	$0.73 - $2.73 $439 - $1,643	-602 Reduced 1.66%	35,637 $84,000
Q4 2023 Feb 01, 2024	SELL	$0.38 - $0.91 $100 - $241	-265 Reduced 0.73%	36,239 $32,000
Q3 2023 Nov 07, 2023	SELL	$0.79 - $2.83 $49,217 - $176,309	-62,300 Reduced 63.05%	36,504 $31,000
Q2 2023 Aug 07, 2023	SELL	$2.49 - $20.59 $66,545 - $550,267	-26,725 Reduced 21.29%	98,804 $267,000
Q1 2023 May 02, 2023	BUY	$15.95 - $25.18 $542,124 - $855,843	33,989 Added 37.13%	125,529 $2.34 Million
Q4 2022 Jan 30, 2023	BUY	$13.27 - $17.73 $127,219 - $169,977	9,587 Added 11.7%	91,540 $1.47 Million
Q3 2022 Nov 08, 2022	BUY	$11.4 - $14.6 $1,949 - $2,496	171 Added 0.21%	81,953 $1.07 Million
Q2 2022 Aug 04, 2022	SELL	$7.94 - $12.96 $1,143 - $1,866	-144 Reduced 0.18%	81,782 $864,000
Q1 2022 May 05, 2022	BUY	$12.02 - $16.79 $56,361 - $78,728	4,689 Added 6.07%	81,926 $985,000
Q4 2021 Feb 02, 2022	SELL	$9.93 - $15.39 $1,886 - $2,924	-190 Reduced 0.25%	77,237 $1.09 Million
Q3 2021 Nov 02, 2021	SELL	$10.18 - $26.64 $57,903 - $151,528	-5,688 Reduced 6.84%	77,427 $791,000
Q2 2021 Aug 02, 2021	SELL	$18.57 - $35.68 $2.42 Million - $4.65 Million	-130,219 Reduced 61.04%	83,115 $2.21 Million
Q4 2020 Feb 08, 2021	SELL	$37.09 - $48.97 $2.79 Million - $3.69 Million	-75,335 Reduced 26.1%	213,334 $7.91 Million
Q3 2020 Nov 05, 2020	BUY	$40.47 - $45.5 $3.07 Million - $3.46 Million	75,938 Added 35.7%	288,669 $11.9 Million
Q2 2020 Aug 07, 2020	BUY	$32.57 - $42.83 $136,794 - $179,886	4,200 Added 2.01%	212,731 $8.62 Million
Q4 2019 Feb 05, 2020	SELL	$34.58 - $48.06 $359,632 - $499,824	-10,400 Reduced 4.75%	208,531 $8.94 Million
Q3 2019 Nov 07, 2019	BUY	$36.98 - $48.45 $92,449 - $121,125	2,500 Added 1.16%	218,931 $8.1 Million
Q2 2019 Aug 09, 2019	BUY	$35.13 - $55.53 $1.81 Million - $2.86 Million	51,468 Added 31.2%	216,431 $9.78 Million
Q1 2019 May 08, 2019	BUY	$42.83 - $59.91 $3.92 Million - $5.49 Million	91,563 Added 124.75%	164,963 $8.97 Million
Q4 2018 Feb 08, 2019	SELL	$37.97 - $60.16 $432,858 - $685,824	-11,400 Reduced 13.44%	73,400 $3.4 Million
Q3 2018 Nov 07, 2018	SELL	$56.3 - $67.25 $312,465 - $373,237	-5,550 Reduced 6.14%	84,800 $5.15 Million
Q2 2018 Aug 10, 2018	BUY	$44.9 - $64.95 $561,250 - $811,875	12,500 Added 16.06%	90,350 $5.66 Million
Q1 2018 May 10, 2018	BUY	$45.35 - $61.65 $403,615 - $548,685	8,900 Added 12.91%	77,850 $3.6 Million
Q4 2017 Feb 13, 2018	SELL	$41.95 - $60.1 $110,706 - $158,603	-2,639 Reduced 3.69%	68,950 $3.27 Million
Q3 2017 Nov 06, 2017	BUY	$33.4 - $53.9 $129,892 - $209,617	3,889 Added 5.74%	71,589 $3.85 Million
Q2 2017 Aug 11, 2017	BUY	N/A	67,700	67,700 $2.19 Million

Others Institutions Holding FGEN

# of Institutions

Shares Held

47.1M

Call Options Held

387K

Put Options Held

672K

Primecap Management CO Pasadena, CA

9.91M
Shares

$3.47 Million
0.0% of portfolio
Armistice Capital, LLC New York, NY

6.8M
Shares

$2.38 Million
0.05% of portfolio
Vanguard Group Inc Valley Forge, PA

5.88M
Shares

$2.06 Million
0.0% of portfolio
Acadian Asset Management LLC Boston, MA

3.91M
Shares

$1.37 Million
0.0% of portfolio
Black Rock Inc. New York, NY

2.41M
Shares

$843,377
0.0% of portfolio

View Full List

About FIBROGEN INC

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $32.8M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

More about FGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.

Account